Showing results (361-370 of 414) with videos related to

Sort By:
Pageof 42
Cancer|July 1, 1997
Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patientsT H Douglas, T O Morgan, D G McLeod, et al.
The Prostate|December 1, 1999
Use of artificial neural networks in evaluating prognostic factors determining the response to dendritic cells pulsed with PSMA peptides in prostate cancer patientsG P Murphy, P Snow, S J Simmons, et al.
The Prostate|October 1, 1994
Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patientsY P Rochon, J S Horoszewicz, A L Boynton, et al.
The Prostate|July 1, 1999
Follow-up evaluation of a phase II prostate cancer vaccine trialB A Tjoa, S J Simmons, A Elgamal, et al.
The Prostate|May 27, 1999
GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trialS J Simmons, B A Tjoa, M Rogers, et al.
Cancer Treatment Reports|March 1, 1977
National randomized study of chemotherapeutic agents in advanced prostatic carcinoma: a progress reportD E Johnson, W W Scott, R P Gibbons, et al.
The Prostate|August 4, 1998
Method for identifying prostate cells in semen using flow cytometryR J Barren, E H Holmes, A L Boynton, et al.
Seminars in Surgical Oncology|January 5, 2000
Prostate-specific membrane antigen (PSMA): current benefits and future valueA A Elgamal, E H Holmes, S L Su, et al.
The Prostate|July 1, 1995
Pathology review in an early prostate cancer detection program: results from the American Cancer Society-National Prostate Cancer Detection ProjectF K Mostofi, G P Murphy, C Mettlin, et al.
Urology|April 1, 1997
Evaluation and follow-up of patients with N1-3 M0 or NXM1 prostate cancer in phase III trialsR Hall, P O Hedlund, R Ackermann, et al.
Pageof 42